News SI-BONE, Inc.

Equities

SIBN

US8257041090

Real-time Estimate Cboe BZX Other stock markets 10:31:36 2024-04-25 am EDT			5-day change	1st Jan Change
14.35 ^USD	-4.84%		-5.95%	-31.44%

Mar. 28	Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	MT
Mar. 12	Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024	Apr. 15	AQ
Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	Mar. 28	MT
Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM	Mar. 12
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024	Mar. 04	AQ
Morgan Stanley Raises SI-Bone Price Target to $26 From $25, Maintains Overweight Rating	Feb. 27	MT
Truist Securities Adjusts SI-Bone Price Target to $24 From $26, Maintains Buy Rating	Feb. 27	MT
Si-Bone: Q4 Earnings Snapshot	Feb. 26	AQ
Transcript : SI-BONE, Inc., Q4 2023 Earnings Call, Feb 26, 2024	Feb. 26
Earnings Flash (SIBN) SI-BONE Posts Q4 Revenue $38.9M, vs. Street Est of $38.6M	Feb. 26	MT
SI-BONE, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 26	CI
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance	Feb. 26	AQ
SI-BONE, Inc. Provides Earnings Guidance for the Year 2024	Feb. 26	CI
Si-bone Insider Sold Shares Worth $808,591, According to a Recent SEC Filing	Feb. 21	MT
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024	Feb. 05	AQ
SI-Bone Implant Receives Expanded FDA Approval	Jan. 30	MT
SI-Bone Shares Up After Receiving FDA Approval for Expanded Device Use	Jan. 30	DJ
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	Jan. 30	AQ
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application	Jan. 30	CI
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023	Jan. 08	AQ
SI-Bone, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	Jan. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SI-BONE, Inc.

Equities

SIBN

US8257041090

Summary

Filters